ArticleInternational journal of women's dermatology2026
Addressing dermatologic toxicities in gynecologic cancer: development and evaluation of a patient education pamphlet.
Article in International journal of women's dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Background: Cancer patients commonly experience distressing dermatologic changes as a result of their cancer therapy. Patient education on managing these side effects remains limited and inadequately represents diverse skin tones, especially in gynecologic cancer. We aimed to create an educational pamphlet to inform gynecologic cancer patients across skin tones about potential dermatologic changes during cancer therapy. Objective: To develop and pilot an inclusive educational pamphlet to improve dermatologic toxicity knowledge in gynecologic cancer patients. Methods: An educational pamphlet about dermatologic changes during cancer therapy was designed using representative images and information appropriate for skin of color and non-skin of color patients. Feedback and pre/post knowledge surveys were distributed to patients with a diagnosis of gynecologic cancer via the ResearchMatch platform and via MyChart and in-person at the Smilow Cancer Hospital infusion center. Results: Forty-six individuals participated in this study. Among respondents, most identified as female (96%) and were predominantly White (63%) or Black (21.7%). Mean age was 67.3 (range 40-83). All participants had attained at least a high-school education. Our educational intervention led to a significant increase in knowledge regarding potential skin, hair, and nail changes from cancer treatments: participants reported a subjective increase in knowledge ( Limitations: Small sample size, single-center recruitment, and limited racial and ethnic diversity, which restricted subgroup analyses. Conclusion: This pilot study highlights the effectiveness of an educational pamphlet tailored to dermatologic changes during gynecologic cancer therapy, emphasizing inclusivity across skin tones. Future research should evaluate its long-term impact on patient outcomes and expand its application to broader cancer populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.